Increased Intake of Ultraprocessed Food Raises Lung Cancer Risk
By Elana Gotkine HealthDay Reporter

THURSDAY, July 31, 2025 -- Higher consumption of ultraprocessed foods (UPF) is associated with increased risk of lung cancer, according to a study published online July 29 in Thorax.
Kanran Wang, from Chongqing Cancer Hospital in China, and colleagues collected data from participants from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial to examine the association of UPF with increased risk of lung cancer, non-small cell lung cancer (NSCLC), and small cell lung cancer (SCLC). A validated diet history questionnaire was used to assess dietary intakes.
During a mean follow-up of 12.2 years among 101,732 adults, a total of 1,706 lung cancer cases were identified: 1,473 NSCLC and 233 SCLC. The researchers found that individuals in the highest versus the lowest quarter for UPF consumption had increased risk of lung cancer, NSCLC, and SCLC after multivariable adjustments, including key risk factors related to lung cancer and overall diet quality (hazard ratios, 1.41, 1.37, and 1.44, respectively). After a large range of subgroup and sensitivity analyses, these results remained statistically significant.
"These findings need to be confirmed by other large-scale longitudinal studies in different populations and settings," the authors write. "If causality is established, limiting trends of UPF intake globally could contribute to reducing the burden of lung cancer."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-08-01 06:00
Read more

- Association Found Between Home Mold, Hypersensitivity Pneumonitis
- Antidepressant Withdrawal Not As Severe As Thought, Evidence Review Says
- AI Displays Racial Bias Evaluating Mental Health Cases
- Guselkumab Efficacious for Moderately to Severely Active Crohn Disease in Adults
- FDA Elevates Dubai Chocolate Spread Recall to Class 1 Over Salmonella Risk
- Shorla Oncology Announces FDA Orphan Drug Designation for SH-110 to Treat Rare Brain Cancer Using Oral Liquid
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions